1:15-cv-00920 - Vanda Pharmaceuticals Inc v. Taro Pharmaceuticals USA Inc et al.Report Error
Detail
Case Number
1:15-cv-00920Current Status
closedCause of Action
Infringement
Related Case(s)
1:13-cv-01973
1:14-cv-00757
1:15-cv-00362
1:15-cv-00919
1:15-cv-00921
1:15-cv-00922
1:15-cv-01073
Court
Delaware District CourtPlaintiff(s)
Vanda Pharmaceuticals Inc
Operating CompanyDefendant(s)
Taro Pharmaceuticals USA Inc
Taro Pharmaceutical Industries Ltd
Judge
Gregory M. SleetFiling Date
2015-10-13Termination Date
2016-10-27Dockets
Text |
---|
CIVIL DOCKET |
UPDATED CIVIL DOCKET |
Summons Issued with Magistrate Consent Notice attached as to Taro Pharmaceutical Industries, Ltd. on 10/14/2015; Taro Pharmaceuticals USA, Inc. on 10/14/2015. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sec) (Entered: 10/14/2015) |
COMPLAINT FOR PATENT INFRINGEMENT filed against Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806822.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(sec) (Entered: 10/14/2015) |
Joint STATUS REPORT by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Letter to The Honorable Gregory M. Sleet, # 2 [Proposed] Scheduling Order)(Townsend, Ethan) (Entered: 02/09/2016) |
PROPOSED ORDER -- [Proposed] Scheduling Order -- by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Letter to The Honorable Gregory M. Sleet)(Townsend, Ethan) (Entered: 04/14/2016) |
ORAL ORDER: On or before September 7, 2016, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in the attached Order. Ordered by Judge Thynge on 8/15/16. (Attachments: # 1 Affidavit Order Requesting Information re: ADR) (cak) (Entered: 08/15/2016) |
NOTICE of Issuance of Subpoena on Curt Wolfgang, Ph.D. by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Inventia Healthcare Pvt. Ltd., Roxane Laboratories, Inc. (Attachments: # 1 Attachment)(Palapura, Bindu) (Entered: 10/19/2016) |
STIPULATION for Entry of Consent Judgment and Permanent Injunction by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Consent Judgment)(Fahnestock, Derek) (Entered: 10/25/2016) |
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 10/14/2015) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 11/2/2027-U.S. 8,586,610; 9/30/2025-U.S. 9,138,432. Thirty Month Stay Deadline: N/A. (sec) (Entered: 10/14/2015) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,586,610; 9,138,432. (sec) (Entered: 10/14/2015) |
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vanda Pharmaceuticals Inc. (sec) (Entered: 10/14/2015) |
WAIVER OF SERVICE returned executed by Vanda Pharmaceuticals Inc.: For Taro Pharmaceuticals USA, Inc. waiver sent on 10/27/2015, answer due 12/28/2015. (Jacobs, Karen) (Entered: 10/29/2015) |
WAIVER OF SERVICE returned executed by Vanda Pharmaceuticals Inc.: For Taro Pharmaceutical Industries, Ltd. waiver sent on 10/27/2015, answer due 12/28/2015. (Jacobs, Karen) (Entered: 10/29/2015) |
MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis and Josephine Young - filed by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 11/03/2015) |
MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, William O. Adams, Nathanael R. Luman and Caleb A. Bates of Knobbe, Martens, Olson & Bear, LLP - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc.. (Farnan, Kelly) (Entered: 11/13/2015) |
NOTICE of Appearance by Christine Dealy Haynes on behalf of Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc. (Haynes, Christine) (Entered: 11/17/2015) |
ANSWER to 1 Complaint, , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Taro Pharmaceuticals USA, Inc., Taro Pharmaceutical Industries, Ltd..(Farnan, Kelly) (Entered: 12/28/2015) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Ltd. for Taro Pharmaceutical Industries, Ltd. filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc.. (Farnan, Kelly) (Entered: 12/28/2015) |
ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 12/28/2015. (asw) (Entered: 12/28/2015) |
ANSWER to 11 Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 01/22/2016) |
STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to February 10, 2016 - filed by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 01/26/2016) |
STIPULATION TO EXTEND TIME to submit the proposed scheduling order to April 14, 2016 - filed by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 04/13/2016) |
NOTICE OF SERVICE of (1) Vanda Pharmaceuticals Inc.s Disclosures Pursuant to Delaware Default Standard for Discovery including Discovery of Electronically Stored Information and (2) Plaintiff Vanda Pharmaceuticals Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 04/19/2016) |
NOTICE OF SERVICE of Defendants Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries Ltd.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Defendants Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries, Ltd.s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc..(Farnan, Kelly) (Entered: 04/20/2016) |
MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Klein - filed by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 04/28/2016) |
NOTICE OF SERVICE of Vandas Disclosure of Accused Products and Asserted Patent filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 04/29/2016) |
Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to May 16, 2016 - filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (Entered: 05/02/2016) |
NOTICE of Withdrawal of Counsel by Vanda Pharmaceuticals Inc. (Jacobs, Karen) (Entered: 05/02/2016) |
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to May 23, 2016 - filed by Roxane Laboratories, Inc.. (Palapura, Bindu) (Entered: 05/16/2016) |
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 13, 2016 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 05/23/2016) |
NOTICE OF SERVICE of Vandas Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 06/10/2016) |
STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to June 20, 2016 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 06/13/2016) |
STIPULATION TO EXTEND TIME for the Parties to submit a Proposed Protective Order to June 21, 2016 - filed by Lupin Limited, Lupin Pharmaceuticals Inc.. (Wright, Joseph) (Entered: 06/20/2016) |
PROPOSED ORDER [Proposed] Stipulated Protective Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 06/21/2016) |
NOTICE OF SERVICE of Defendants Initial Invalidity Contentions re Oral Order,,,,, Set/Reset Scheduling Order Deadlines,,,, filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Green, James) (Entered: 07/01/2016) |
NOTICE OF SERVICE of (i) Vandas First Set of Interrogatories to Taro (Nos. 1-14); and (ii) Vandas First Set of Requests for Production of Documents and Things to Taro (Nos. 1-79) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 07/19/2016) |
NOTICE OF SERVICE of Defendants First Set of Joint Interrogatories to Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Inventia Healthcare Pvt. Ltd., Roxane Laboratories, Inc..(Matterer, Mary) (Entered: 10/05/2016) |
NOTICE OF SERVICE of Defendants First Set of Joint Interrogatories to Plaintiffs (Nos. 1-16) directed to U.S. Patent No. 8,586,610 filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Inventia Healthcare Pvt. Ltd..(Matterer, Mary) (Entered: 10/05/2016) |
NOTICE OF SERVICE of (1) Defendants Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries Ltd.s First Set of Interrogatories to Plaintiff (Nos. 1-13) and (2) Defendants Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries Ltd.s First Set of Requests for Production of Documents and Things (Nos. 1-61) filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc..(Farnan, Kelly) (Entered: 10/05/2016) |
NOTICE OF SERVICE of (1) Defendants Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries Ltds Responses to Plaintiffs First Set of Interrogatories (Nos. 1-14) and (2) Defendants Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries Ltds Responses to Plaintiffs First Set of Requests for Production of Documents and Things (Nos. 1-79) filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc..(Farnan, Kelly) (Entered: 10/07/2016) |
NOTICE to Take Deposition of Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries, Ltd. on November 4, 2016 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 10/07/2016) |
NOTICE OF SERVICE of Defendants Second Set of Interrogatories to Plaintiffs (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Inventia Healthcare Pvt. Ltd., Roxane Laboratories, Inc..(Palapura, Bindu) (Entered: 10/10/2016) |
NOTICE to Take Deposition of Mihael H. Polymeropoulos on November 9, 2016 (filed on behalf of all Defendants) filed by Roxane Laboratories, Inc..(Palapura, Bindu) (Entered: 10/12/2016) |
Joint NOTICE of 30(b)(6) Deposition to Vanda Pharmaceuticals Inc. by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Roxane Laboratories, Inc. (Matterer, Mary) (Entered: 10/13/2016) |
[SEALED] NOTICE of Subpoena and Deposition of Novartis Pharmaceuticals Corp. and Novartis Pharma AG by Inventia Healthcare PVT Ltd., Roxane Laboratories, Inc., Apotex Inc., Apotex Corp., Taro Pharmaceuticals USA, Inc., Taro Pharmaceutical Industries, Ltd., Lupin Limited and Lupin Pharmaceuticals, Inc. (Matterer, Mary) Modified on 10/18/2016 (mdb). (Entered: 10/18/2016) |
NOTICE of Subpoena and Deposition of Gustavo Alva, M.D. by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc. (Matterer, Mary) (Entered: 10/20/2016) |
[SEALED] NOTICE of Subpoena and Deposition to Novartis Pharmaceuticals Corp. (Revised) by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Roxane Laboratories, Inc. (Matterer, Mary) (Entered: 10/24/2016) |
REDACTED VERSION of (41 in 1:15-cv-00921-GMS, 69 in 1:15-cv-01073-GMS, 42 in 1:15-cv-00920-GMS, 57 in 1:15-cv-00362-GMS, 38 in 1:15-cv-00919-GMS, 58 in 1:15-cv-00922-GMS) Notice (Other), by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Roxane Laboratories, Inc.. (Matterer, Mary) Modified on 10/25/2016 (mdb). (Entered: 10/24/2016) |
REDACTED VERSION of (44 in 1:15-cv-00921-GMS, 72 in 1:15-cv-01073-GMS, 60 in 1:15-cv-00362-GMS, 61 in 1:15-cv-00922-GMS, 40 in 1:15-cv-00919-GMS, 45 in 1:15-cv-00920-GMS) Notice (Other), (Redacted Public Version of Revised Notice of Subpoena and Deposition to Novartis Pharmaceuticals Corp.) by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals USA, Inc., Inventia Healthcare PVT Ltd., Apotex Corp., Apotex Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Roxane Laboratories, Inc.. (Matterer, Mary) Modified on 10/27/2016 (mdb). (Entered: 10/27/2016) |
CONSENT JUDGMENT and Permanent Injunction - re 47 Stipulation. CASE CLOSED. Signed by Judge Gregory M. Sleet on 10/27/2016. (mdb) (mdb). Modified on 10/27/2016 (mdb). (Entered: 10/27/2016) |
Timeline
filed_date
closed_date
Oct
Nov
Dec
2016
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2017
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Patents In Case